ALPS Advisors’s Alpine Immune Sciences Inc ALPN Stock Holding History

ALPS Advisors’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-46,222	Closed	-$1.83M	–	1014
2024 Q1	$1.83M	Buy	46,222 +6,631	+17%	+$196K	0.01%	369
2023 Q4	$755K	Buy	+39,591	New	+$550K	0.01%	544
2022 Q2	–	Sell	-30,030	Closed	-$269K	–	1098
2022 Q1	$269K	Sell	30,030 -3,785	-11%	-$32.7K	﹤0.01%	779
2021 Q4	$468K	Buy	33,815 +4,511	+15%	+$55.9K	0.01%	528
2021 Q3	$313K	Sell	29,304 -2,194	-7%	-$20.2K	﹤0.01%	854
2021 Q2	$283K	Buy	+31,498	New	+$342K	﹤0.01%	865

ALPS Advisors's ALPN Position: Q2 2024 in Review

ALPS Advisors sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 46,222 shares — an estimated $1.83M sold.

ALPS Advisors first reported a position in ALPN in Q2 2021 and held it in 6 quarters. The position peaked at $1.83M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

ALPS Advisors reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
ALPS Advisors sold 46,222 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $1.83M.
ALPS Advisors first reported a position in Alpine Immune Sciences Inc in Q2 2021 and held it in 6 quarters.
ALPS Advisors's Alpine Immune Sciences Inc position peaked at $1.83M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on ALPS Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.